{"id":"W4253323776","doi":"10.1200/jco.2013.31.15_suppl.2053","title":"Phase II study of PX-866 in recurrent glioblastoma.","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Manitoba; BC Cancer Agency; University of Alberta; Queen Elizabeth II Health Sciences Centre; University of Toronto; University Health Network; Dalhousie University; Cancer Care Ontario; Queen's University","funders":"","keywords":"Medicine; Temozolomide; Nausea; Internal medicine; Gastroenterology; Phases of clinical research; Adverse effect; Oncology; PTEN; Surgery; Toxicity; Chemotherapy; PI3K/AKT/mTOR pathway; Signal transduction","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00129199,0.001561053,0.001773961,0.0005995293,0.0003133666,0.0005256878,0.0008084298,0.00091323,0.003597836],"category_scores_gemma":[0.0004721014,0.0005375776,0.0009002446,0.000441866,0.0006746842,0.0004252037,0.0004472749,0.002049554,0.001166311],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006445918,"about_ca_system_score_gemma":0.001632415,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001249681,"about_ca_topic_score_gemma":0.002719264,"domain_scores_codex":[0.9996063,0.0001835524,0.00002604765,0.00004753323,0.00004141685,0.00009508608],"domain_scores_gemma":[0.9996283,0.00004002032,0.00007805436,0.00004011324,0.00002956307,0.0001839873],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5529043,0.1092546,0.01152272,0.001694626,0.001250925,0.0006903349,0.0006031438,0.004505812,0.1303218,0.000615879,0.006282107,0.1803537],"study_design_scores_gemma":[0.2018632,0.7699925,0.01470643,0.00004235837,0.0003259161,0.0006665302,0.00006528549,0.001345079,0.008282427,0.0001719507,0.002514986,0.00002344585],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9943381,0.001085753,0.0005108652,0.0001775011,0.00006560988,0.002190652,0.0006552424,0.00009924875,0.0008769149],"genre_scores_gemma":[0.9878858,0.001465741,0.001734015,0.0003773311,0.00009592949,0.002870372,0.00239727,0.00003347159,0.003139973],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003597836,"threshold_uncertainty_score":0.01203591,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1780430097485797,"score_gpt":0.5697458970082092,"score_spread":0.3917028872596295,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}